 |
Apply for the Codman Fellowship in Neurotrauma and Critical Care. Application deadline is January 31, 2012. For more information click
here.
Telemedicine Technology
On August 29, 2011, the U.S. Department of Health and Human Services, Office of Inspector General (OIG) issued favorable Advisory Opinion 11-12 relating to a health system's provision of neuro emergency clinical protocols and immediate consultations with stroke neurologists via telemedicine technology to certain community hospitals.
Read more... The Agency for Healthcare Research and Quality released a
consumer guide
for a previous published TBI and depression comparative effectiveness review (for the Spanish version please click
here).
Traumatic Brain Injury Studies at NIH Learn about all the traumatic brain injury studies at NIH sponsored by the Center for Neuroscience and Regenerative Medicine!
Gutamate is the most pervasive neurotransmitter in the central nervous system. Problems with how glutamate functions in the brain have been linked to a wide variety of disorders, including schizophrenia, Alzheimer's, substance abuse, and traumatic brain injury. Efforts to understand, treat, and prevent glutamate-related disorders can be aided by the identification of valid biomarkers-measures of biological processes that provide information about the state of a disease or a patient's response to treatment. Scientifically-validated glutamate biomarkers can streamline research, increase researchers' understanding of how glutamate-related disorders function, and accelerate the development of methods to treat and prevent these disorders.
The IOM's Forum on Neuroscience and Nervous System Disorders held a workshop June 21-22, 2010, to explore ways to accelerate the development, validation, and implementation of glutamate-related biomarkers. Participants discussed the most promising current and emerging technologies for discovering glutamate-related biomarkers, and identified gaps in current research. In addition, participants considered possible approaches to validating biomarkers and the barriers to implementing these biomarkers in a way that would accelerate drug development. The document summarizes the workshop. Rachel Groma Senior Manager, Quality Improvement and Research Joint Section on Neurotrauma and Critical Care Position Statement on Traumatic Brain Injury in Sports
(Statement Approved by the AANS Board of Directors and CNS Executive Committee on 4/8/11)
Sports and recreational activities contribute significantly to personal health, well-being, and satisfaction throughout all stages of life. However, inherent to many of these activities is risk to the individual participant. Traumatic brain injuries (TBI), including concussions, may occur in a variety of sports and recreational settings, and participants should be educated as much as possible about the risks, safety measures, and protective equipment that are available to them. Equally important is understanding the potential long-term effects of both isolated and repeated TBI. Read more... |